scispace - formally typeset
K

Kimberly D. Miller

Researcher at American Cancer Society

Publications -  54
Citations -  127607

Kimberly D. Miller is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 30, co-authored 46 publications receiving 86928 citations.

Papers
More filters
Journal ArticleDOI

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

TL;DR: These results may underestimate the overall proportion of cancers attributable to modifiable factors, because the impact of all established risk factors could not be quantified, and many likely modifiable risk factors are not yet firmly established as causal.
Journal ArticleDOI

Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

TL;DR: Age-specific CRC risk has escalated back to the level of those born circa 1890 for contemporary birth cohorts, underscoring the need for increased awareness among clinicians and the general public, as well as etiologic research to elucidate causes for the trend.
Journal ArticleDOI

Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities

TL;DR: Although blacks continue to have higher cancer death rates than whites, the disparity has narrowed and the racial gap in death rates has widened for all cancers combined in men and women and for lung and prostate cancers in men.
Journal ArticleDOI

Cancer statistics for African Americans, 2019

TL;DR: Overall cancer death rates declined faster in blacks than whites among both males and females, largely driven by greater declines for cancers of the lung, colorectum, and prostate, and the black‐white cancer disparity has been nearly eliminated in men <50 years and women ≥70 years.
Journal ArticleDOI

Cancer statistics for adolescents and young adults, 2020.

TL;DR: Progress in reducing cancer morbidity and mortality among AYAs could be addressed through more equitable access to health care, increasing clinical trial enrollment, expanding research, and greater alertness among clinicians and patients for early symptoms and signs of cancer.